Table 3.
Clinical characteristics of the CHB liver fibrosis and liver cirrhosis group cases ().
| Clinical data | Liver fibrosis group | Liver cirrhosis group | p |
|---|---|---|---|
| Male/female | 21/11 | 30/18 | 0.815 |
| Age (years old) | 38 ± 12 | 52 ± 11 | 0.0001 |
| Blood cell counts (109/L) | 5.6 ± 2.0 | 4.6 ± 1.6 | 0.025 |
| Hemoglobin (g/L) | 145 ± 23 | 124 ± 28 | 0.001 |
| Blood platelet (109/L) | 155 ± 12 | 112 ± 15.5 | 0.002 |
| ALT (U/L) | 84 ± 16.3 | 60 ± 21.2 | 0.285 |
| AST (U/L) | 71 ± 21 | 39 ± 11.2 | 0.023 |
| γ-GT (U/L) | 54 ± 12.1 | 53 ± 31.2 | 0.926 |
| ALP (U/L) | 90 ± 32.1 | 90 ± 17.3 | 0.985 |
| T-Bil (μmol/L) | 22 ± 12.1 | 35 ± 13.2 | 0.160 |
| D-Bil (μmol/L) | 9.9 ± 1.8 | 19.1 ± 9.5 | 0.177 |
| TP (g/L) | 68 ± 13 | 65 ± 8.3 | 0.244 |
| ALB (g/L) | 39 ± 9.6 | 35 ± 6.7 | 0.104 |
| TC (U/L) | 4.5 ± 1.1 | 3.7 ± 0.8 | 0.004 |
| TG (U/L) | 1.3 ± 0.6 | 0.9 ± 0.3 | 0.003 |
| AFP | 14 ± 11.1 | 45 ± 8.5 | 0.029 |
| INR | 1 ± 0.2 | 1.4 ± 0.6 | 0.001 |
| HBV-DNA (107 U/L) | 8.7 ± 0.6 | 6.3 ± 0.7 | 0.932 |
| HBeAg-positive rate (%)∗ | 95% | 45% | 0.0001 |